GLP-1

A recent paper shared the results of a 5 year observation study of 12,000 individuals with Obesity taking GLP-1 drugs (e.g., Ozempic, Wegovy) by a collection of Chinese researchers.

There’s an impressive looking graph in the paper that shows a significant reduction in adverse outcomes (stroke, cardiovascular issues, etc.).

A commentor on the thread, Hank Green, summarized the punchline beautifully.

That’s a ~90% improvement in mortality.

There’s a lot we need to fix in our society with regards to diet and movement. There’s far too much ultra-processed food going around and far too less exercise.

But such changes take time. Obesity needs urgent attention. And while we’re still early in understanding the long-term impact, a 90% reduction in the odds of death should make us all sit up and take notice.

1 Views
 0
 0